Northern Trust Corp Aquestive Therapeutics, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 194,024 shares of AQST stock, worth $915,793. This represents 0.0% of its overall portfolio holdings.

Number of Shares

194,024

Previous 97,920 98.15%

Holding current value

$915,793

Previous $417,000 20.86%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.31 - $4.5 $222,000 - $432,468	96,104 Added 98.15%	194,024 $504,000
Q1 2024 May 14, 2024	BUY	$2.01 - $6.09 $13,523 - $40,973	6,728 Added 7.38%	97,920 $417,000
Q4 2023 Feb 13, 2024	BUY	$1.29 - $2.47 $33,142 - $63,459	25,692 Added 39.22%	91,192 $184,000
Q2 2023 Aug 11, 2023	BUY	$1.06 - $2.49 $6,012 - $14,123	5,672 Added 9.48%	65,500 $108,000
Q1 2023 May 15, 2023	SELL	$0.72 - $1.15 $1,628 - $2,601	-2,262 Reduced 3.64%	59,828 $68,000
Q3 2022 Nov 14, 2022	BUY	$0.63 - $1.73 $9,160 - $25,155	14,541 Added 30.58%	62,090 $73,000
Q2 2022 Aug 12, 2022	SELL	$0.64 - $2.57 $6 - $25	-10 Reduced 0.02%	47,549 $30,000
Q1 2022 May 13, 2022	BUY	$2.28 - $4.26 $22 - $42	10 Added 0.02%	47,559 $124,000
Q4 2021 Feb 08, 2022	BUY	$3.69 - $6.37 $6,715 - $11,593	1,820 Added 3.98%	47,549 $185,000
Q3 2021 Nov 15, 2021	BUY	$3.25 - $4.66 $893 - $1,281	275 Added 0.61%	45,729 $199,000
Q2 2021 Aug 13, 2021	SELL	$3.29 - $5.21 $549,258 - $869,799	-166,948 Reduced 78.6%	45,454 $181,000
Q1 2021 May 12, 2021	SELL	$4.17 - $6.73 $55,052 - $88,849	-13,202 Reduced 5.85%	212,402 $1.1 Million
Q4 2020 Feb 11, 2021	SELL	$4.65 - $7.79 $29,290 - $49,069	-6,299 Reduced 2.72%	225,604 $1.21 Million
Q3 2020 Nov 16, 2020	SELL	$4.12 - $9.09 $24,110 - $53,194	-5,852 Reduced 2.46%	231,903 $1.13 Million
Q2 2020 Aug 14, 2020	BUY	$1.84 - $6.44 $350,429 - $1.23 Million	190,451 Added 402.61%	237,755 $1.16 Million
Q1 2020 May 14, 2020	BUY	$1.54 - $6.75 $51,323 - $224,957	33,327 Added 238.44%	47,304 $104,000
Q4 2019 Feb 14, 2020	SELL	$3.06 - $8.78 $2,527 - $7,252	-826 Reduced 5.58%	13,977 $81,000
Q3 2019 Nov 13, 2019	SELL	$3.04 - $4.91 $254,870 - $411,649	-83,839 Reduced 84.99%	14,803 $47,000
Q2 2019 Aug 13, 2019	SELL	$3.72 - $6.95 $28,376 - $53,014	-7,628 Reduced 7.18%	98,642 $414,000
Q1 2019 May 13, 2019	BUY	$5.74 - $8.05 $276,673 - $388,018	48,201 Added 83.01%	106,270 $734,000
Q4 2018 Feb 12, 2019	BUY	$6.09 - $18.0 $1,930 - $5,706	317 Added 0.55%	58,069 $366,000
Q3 2018 Nov 14, 2018	BUY	$15.0 - $18.96 $866,280 - $1.09 Million	57,752 New	57,752 $1.01 Million

Others Institutions Holding AQST

# of Institutions

Shares Held

42.7M

Call Options Held

271K

Put Options Held

212K

View Full List

About Aquestive Therapeutics, Inc.

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $252M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

More about AQST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Aquestive Therapeutics, Inc. Transaction History